AZD 2066 sulfate 

AZD 2066 sulfate is a mGluR5 antagonist and also the sulfate salt of 4-(5-{(1R)-1-ethoxy}-4-methyl-4H-1,2,4-triazol-3-yl) pyridine. AZD 2066 sulfate is used in research on various diseases including Alzheimer's disease, autism, and obesity^[1].

AZD 2066 sulfate is used in the research of gastroesophageal reflux disease, Alzheimer's disease, senile dementia, AIDS-induced dementia, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, migraine, epilepsy, schizophrenia, depression, anxiety disorder, acute anxiety disorder, obsessive-compulsive disorder, retinopathy, diabetic retinopathy, glaucoma, tinnitus, chemotherapy-induced neuropathy, postherpetic neuralgia, trigeminal neuralgia, tolerance, dependence, addiction, craving disorder, fragile X syndrome, autism, mental retardation, Down syndrome, inflammatory pain, neuropathic pain, arthritis, rheumatism, low back pain, postoperative pain, angina pectoris, renal colic, biliary colic, dysmenorrhea, gout, stroke, head trauma, hypoxic injury, ischemic injury, hypoglycemia, cardiovascular disease, irritable bowel syndrome, functional dyspepsia, cough, and obesity^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

479.89

C₁₉H₁₈ClN₅O₆S

934282-57-2

O=S(O)(O)=O.CN1C(C2=CC=NC=C2)=NN=C1O[C@@H](C3=NOC(C4=CC(Cl)=CC=C4)=C3)C

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Minidis A, et al. 5-(Phenylisoxazolylethoxy)-Triazol-3-Yl Substituted Pyridine Compounds for the Treatment of Neurological, Psychiatric or Pain Disorders: U.S. Patent Application 12/067,270[P]. 2008-9-18.